EN DE
STOCK COMPARISON

Sino Medical Sciences Technology In vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Sino Medical Sciences Technology In (688108) and Abbott Laboratories (ABT) compare, as of Sep 14, 2026.

As of Sep 14, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Sino Medical Sciences Technology In trades at ¥15.32 versus a fair value of ¥4.23 (-72%), while Abbott Laboratories trades at $102 versus $74.79 (-27%).
Sino Medical Sciences Technology In
688108.SHG · CNY · Health Care
-72%
upside to fair value
overvalued
Price¥15.32
Fair Value¥4.23
Quality69/100
Abbott Laboratories
ABT · USD · Health Care
-27%
upside to fair value
overvalued
Price$102
Fair Value$74.79
Quality66/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Sino Medical Sciences Technology InAbbott Laboratories
Valuation
115.3×P/E (TTM)27.7×
13.67×P/S (TTM)3.89×
8.28×P/B3.36×
49.0×EV/EBITDA15.1×
PEG1.47×
−72.4%Fair value upside−26.6%
0.1%Dividend yield2.3%
Dividend per share$2.44
Profitability
23%Operating margin13%
1.74×EBIT margin trend (5Y)1.19×
7%Return on equity12%
4%Return on assets6%
Growth
39%Revenue growth (YoY)8%
39.7%Avg. growth/yr (3Y)0.5%
9.9%Avg. growth/yr (5Y)5.1%
−5.6%Value creation/yr+10.5%
Balance & size
13.2×Interest coverage (EBIT/interest)23.6×
Debt / equity0.19×
$1BMarket cap$175B
mixedGrowth qualityhealthy

Abbott Laboratories leads: 4 to 10 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Sino Medical Sciences Technology Inof which business quality 69 · market factors 17 Abbott Laboratoriesof which business quality 66 · market factors 49
ProfitabilityMargins and returns on capital today
40
50
Quality GrowthAre margins and returns improving?
84
47
CashflowEarnings quality: real cash, not paper profit
88
71
Fin. StrengthBalance sheet, leverage, solvency risk
96
80
InvestmentDisciplined investing over empire-building
69
65
Low VolatilityCalm price path (market factor)
47
83
MomentumPrice trend over the last 3–12 months (market factor)
7
40
52W MomentumDistance to the 52-week high (market factor)
1
25
Net IssuanceShare count: buybacks or dilution?
32
84

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familySino Medical Sciences Technology InPrice ¥15.32Abbott LaboratoriesPrice $102
DCF Models-65%below the price¥5.34-28%below the price$73.01
Earnings-Based-88%below the price¥1.84-71%below the price$29.42
Dividend Discount-99%below the price¥0.17-61%below the price$39.73
Multiples-82%below the price¥2.76-31%below the price$70.72
Asset-Based-90%below the price¥1.49-80%below the price$20.05
Growth DCF-62%below the price¥5.82-34%below the price$67.02
Economic Profit-88%below the price¥1.89-63%below the price$37.49
Growth Earnings-84%below the price¥2.41-31%below the price$70.25
Minimum-99%below the price¥0.17-80%below the price$20.05
Maximum-62%below the price¥5.82-28%below the price$73.01
Median-86%below the price¥2.15-48%below the price$53.37
Geometric mean-88%below the price¥1.91-55%below the price$46.36

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Sino Medical Sciences Technology In: 26 of 26 models see the stock below the current price.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Sino Medical Sciences Technology In
Price ¥15.32
Fair Value ¥4.23
Bear ¥3.18Bull ¥5.34
Abbott Laboratories
Price $102
Fair Value $74.79
Bear $51.13Bull $94.43

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Sino Medical Sciences Technology In · Health Care

Quality score69 · Top 25%
Fair value upside-72% · bottom 25%

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside-27% · below median

Bottom line

As of Sep 14, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Sino Medical Sciences Technology In trades at ¥15.32 versus a fair value of ¥4.23 (-72%), while Abbott Laboratories trades at $102 versus $74.79 (-27%).

Sino Medical Sciences Technology In has the higher quality score (69/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.